Genentech

Genentech Inc is a wholly-owned subsidiary of Roche, is a biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals produced by recombinant DNA technology. Genentech's major medical areas of research focus are oncology, immunology, disorders of tissue growth and repair, neuroscience and infectious disease.In January 2023, Kronos Bio Inc entered into a discovery collaboration in the field of oncology with Genentech.In September 2022, Arsenal Biosciences Inc announced a multi-year collaboration with GenentechIn November 2018, Genentech entered into an agreement to acquire Jecure Therapeutics.In July 2014, Genentech entered into a definitive agreement to acquire Seragon Pharmaceuticals Inc and was to make an upfront cash payment of $725 million, and additional contingent payments of up to $1 billion, based on achievement of certain predetermined milestones. At that time, the transaction was expected to close in the third quarter of 2014